These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 4949308

  • 21. Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
    Touw J, Stoner GL, Belehu A.
    Clin Exp Immunol; 1980 Sep; 41(3):397-405. PubMed ID: 6449337
    [Abstract] [Full Text] [Related]

  • 22. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
    Birdi TJ, Mistry NF, Mahadevan PR, Antia NH.
    J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
    [Abstract] [Full Text] [Related]

  • 23. Lepromin stimulates interleukin-2 production and interleukin-2 receptor expression in situ in lepromatous leprosy patients.
    Longley BJ, Haregewoin A, de Beaumount W, Smith KA, Godal T.
    Lepr Rev; 1986 Dec; 57 Suppl 2():189-98. PubMed ID: 3106736
    [No Abstract] [Full Text] [Related]

  • 24. In vitro lymphocyte response to purified protein derivative, BCG and Mycobacterium leprae in a population not exposed to leprosy.
    Closs O.
    Infect Immun; 1975 Jun; 11(6):1163-9. PubMed ID: 1095479
    [Abstract] [Full Text] [Related]

  • 25. Impact of cool temperatures on transformation of human and armadilio lymphocytes (Dasypus novemcinctus, Linn.) as related to leprosy.
    Purtilo DT, Walsh GP, Storrs EE, Banks IS.
    Nature; 1974 Mar 29; 248(447):450-2. PubMed ID: 4596004
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of cell mediated immune responses in untreated cases of leprosy.
    Talwar GP, Krishnan AD, Mehra VL, Blum EA, Pearson JM.
    Clin Exp Immunol; 1972 Oct 29; 12(2):195-203. PubMed ID: 4567646
    [Abstract] [Full Text] [Related]

  • 27. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S, Ramanathan S, Shankernarayan N, Ramu G, Muthukkarauppan V.
    Int J Lepr Other Mycobact Dis; 1996 Mar 29; 64(1):6-14. PubMed ID: 8627115
    [Abstract] [Full Text] [Related]

  • 28. [Induction with bacilli extracted from murine lepromas, of lymphoblastic transformation of lymphocytes from human lepers].
    Merklen FP, Potier JC.
    C R Seances Soc Biol Fil; 1970 Mar 29; 164(6):1230-2. PubMed ID: 4252357
    [No Abstract] [Full Text] [Related]

  • 29. Effect of phytohemagglutinin and various mycobacterial antigens on lymphocyte cultures from leprosy patients.
    Dierks RE, Shepard CC.
    Proc Soc Exp Biol Med; 1968 Feb 29; 127(2):391-5. PubMed ID: 4967852
    [No Abstract] [Full Text] [Related]

  • 30. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.
    Reitan LJ, Closs O.
    Clin Exp Immunol; 1984 Aug 29; 57(2):315-23. PubMed ID: 6380833
    [Abstract] [Full Text] [Related]

  • 31. The response of the patient with leprosy toward Mycobacterium leprae injected with lepromin. A histopathologic study four hours after injection.
    Saúl A.
    Int J Lepr Other Mycobact Dis; 1971 Aug 29; 39(2):300-7. PubMed ID: 4948077
    [No Abstract] [Full Text] [Related]

  • 32. Immunity to leprosy and the Mitsuda reaction.
    Shepard CC.
    Int J Lepr Other Mycobact Dis; 1984 Mar 29; 52(1):74-7. PubMed ID: 6368430
    [No Abstract] [Full Text] [Related]

  • 33. Similar alteractions of lymphoblastic dedifferentiation in lepromatous leprosy patients and their healthy lepromin-negative consanguineous offspring.
    Balina LM, Fliess EL, Bachmann A, Cardama JE, Gatti JC.
    Int J Lepr Other Mycobact Dis; 1973 Mar 29; 41(1):7-13. PubMed ID: 4795537
    [No Abstract] [Full Text] [Related]

  • 34. CD4+ T-cell responses to recombinant hsp65 and hsp18 of M. leprae and their trypsin-digested fragments in leprosy: diversity in HLA-DR restriction.
    Mitra DK, Mehra NK, Maiti TK, Banerjee A, Taneja V, Rajalingam R, Ahuja RK, Bhattacharya BC.
    Int J Lepr Other Mycobact Dis; 1995 Dec 29; 63(4):518-28. PubMed ID: 8642214
    [Abstract] [Full Text] [Related]

  • 35. Suppression of lymph node lymphoproliferation to viable Mycobacterium leprae by peripheral blood-derived monocytes.
    Birdi TJ, Desai S, Antia NH.
    Lepr Rev; 1996 Dec 29; 67(4):338-42. PubMed ID: 9033205
    [No Abstract] [Full Text] [Related]

  • 36. Skin testing with mycobacterial reagents in leprosy.
    Stanford JL.
    Tubercle; 1984 Mar 29; 65(1):63-74. PubMed ID: 6203199
    [No Abstract] [Full Text] [Related]

  • 37. [Lymphocytic blastogenesis in vitro in the immunological study of tuberculosis].
    Zubiani M.
    Lotta Tuberc; 1971 Mar 29; 41(1):64-74. PubMed ID: 5285812
    [No Abstract] [Full Text] [Related]

  • 38. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E, Ulrich M, Aranzazu N, Santaella C, Gallinoto M, Centeno M, Rodriguez V, Convit J.
    Int J Lepr Other Mycobact Dis; 1994 Dec 29; 62(4):552-8. PubMed ID: 7868953
    [Abstract] [Full Text] [Related]

  • 39. Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.
    Godal T, Myrvang B, Samuel DR, Ross WF, Lofgren M.
    Acta Pathol Microbiol Scand Suppl; 1973 Dec 29; 236(0):45-53. PubMed ID: 4602874
    [No Abstract] [Full Text] [Related]

  • 40. Human vaccination studies in normal and contacts of leprosy patients.
    Samuel NM, Stanford JL, Rees RJ, Fairbairn T, Adiga RB.
    Indian J Lepr; 1984 Dec 29; 56(1):36-47. PubMed ID: 6384380
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.